Long-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virus.

AUTOR(ES)

Böttiger, D

RESUMO

Macaques chronically infected with simian immunodeficiency virus were treated with zidovudine (20 mg/kg of body weight per day for 9 weeks) or 3'-fluorothymidine (5 mg/kg of body weight per day for 9 weeks or three doses of 2 mg/kg per day for 24 days). Hematological changes in the treated animals included macrocytic anemia and leukopenia. Determination of antiviral effects in this model requires improved assay methods.

Documentos Relacionados

• Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
• Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus
• Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.
• Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophages.
• Characterization of long-term cultures of hepatitis C virus.